Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

12 trials with published results (8%)

Research Maturity

79 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.4%

8 terminated out of 149 trials

Success Rate

90.8%

+4.3% vs benchmark

Late-Stage Pipeline

10%

15 trials in Phase 3/4

Results Transparency

15%

12 of 79 completed with results

Key Signals

12 with results91% success

Data Visualizations

Phase Distribution

81Total
Not Applicable (47)
Early P 1 (2)
P 1 (12)
P 2 (5)
P 3 (10)
P 4 (5)

Trial Status

Completed79
Recruiting20
Unknown17
Not Yet Recruiting12
Terminated8
Active Not Recruiting7

Trial Success Rate

90.8%

Benchmark: 86.5%

Based on 79 completed trials

Clinical Trials (149)

Showing 20 of 20 trials
NCT07285460Phase 3RecruitingPrimary

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT07516730Not Yet RecruitingPrimary

Central Pain Mechanisms and Clinical and Psychological Factors Associated With Pain Interference in Daily Life in Adults With Hemophilia and Hemophilic Arthropathy

NCT06261593Not ApplicableCompletedPrimary

Blood Flow Restriction in Improving Muscle Strength of Patients With Hemophilic Ankle Arthropathy

NCT07101926RecruitingPrimary

Monitoring of Anti-TFPI in Hemophilia

NCT07454239Active Not RecruitingPrimary

EPOCH-Economics and Patient Outcomes in China in Haemophilia

NCT07452575Not ApplicableNot Yet RecruitingPrimary

3D Ultrasound in Hemophilic Ankles

NCT06543368Not ApplicableCompleted

Low-Cost Platelet-Rich Plasma for Hemarthropathy

NCT07110675CompletedPrimary

Central Sensitisation in Patients With Haemophilia and Degenerative Arthropathy

NCT07420348Not Yet RecruitingPrimary

Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab

NCT07420387Not ApplicableNot Yet RecruitingPrimary

Effectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy

NCT07425327Not Yet RecruitingPrimary

Validity and Reliability of the Two-minute Step Test in Hemophilia

NCT07406139Phase 4RecruitingPrimary

PCC Treatment for Hemophilia Patients With Inhibitor(2022PCC-A)

NCT04645199Recruiting

National Longitudinal Cohort of Hematological Diseases

NCT05662319Phase 3Active Not RecruitingPrimary

A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

NCT05568524Not ApplicableCompletedPrimary

Resistance Training With Blood Flow Restriction in Hemophilia

NCT04390126Completed

COVID-19 Related Lockdown Effects On Chronic Diseases

NCT07161596Not ApplicableNot Yet RecruitingPrimary

Oral Health Status and Oral Health Related Quality of Life in a Group pf Egyptian Hemophilic Children

NCT07339410Not ApplicableCompletedPrimary

Physiotherapy to Improve Balance and Walking Capacity in Hemophilia

NCT04398628Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT06752850Phase 4Active Not Recruiting

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Scroll to load more

Research Network

Activity Timeline